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Abstract
Impetigo is a contagious, superficial bacterial infection of the skin, most frequently encountered in children. Causative 
organisms are almost always Staphylococcus aureus or streptococci, or a combination of the two. Predisposing factors are 
nasal and perineal colonisation, overcrowding, poor personal hygiene, minor skin trauma and pre-existing skin diseases with 
disrupted skin barrier function, like eczema. Infection is mainly acquired through contact with sufferers or nasal carriers. 
Treatment should be given to avoid spread of the disease, and to minimise the risk of infecting others. Although the majority 
of cases of impetigo are self-limiting, under certain circumstances complications like toxic shock syndrome, staphylococcal 
osteomyelitis, septic arthritis and pneumonia can occur. Furthermore, certain strains of group A β-haemolytic streptococci 
causing impetigo may result in poststreptococcal glomerulonephritis, just like streptococcal throat infections can result in 
rheumatic fever in children, but the pathogenesis remains poorly understood. It appears to be due to abnormal immune 
response or hypersensitivity to streptococcal antigens.
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Introduction
Impetigo is a common bacterial skin infection in children. 
Causative organisms are almost always Staphylococcus 
aureus or streptococci, or a combination of the two. Infection 
is usually acquired by skin-to-skin contact, or from contact 
with nasal carriers of these organisms. Impetigo is typically 
classified as primary or secondary. Primary impetigo 
occurs following a bacterial invasion of previously normal 
skin. In secondary impetigo, infection occurs secondary to 
some other underlying skin disease that disrupts the skin 
barrier function, such as atopic eczema, hence the term 
impetiginised eczema.
Discussion
Impetigo is almost always caused by Staphylococcus aureus 
or streptococci, or a combination of the two.¹ Susceptibility 
to these infections depends on host immune factors, as well 
as virulence of the organisms. There are two clinical types, 
impetigo contagiosa and bullous impetigo.²
Impetigo contagiosa
This is the most common form. Usually caused by 
Staphylococcus aureus, streptococci or both, depending 
on geographical variations, with the streptococcal form 
being more prevalent in warmer climates. The early lesion 
of impetigo contagiosa is a very thin-walled vesicle that 
develops on an erythematous base.
The vesicles rupture rapidly, and as a result, they are 
seldom seen. The exuding serum dries to form brownish 
crusts with a characteristic honey colour (Figure 1). In 
some cases, there may be a purulent discharge (Figure 2). 
Satellite lesions occur in the vicinity due to autoinoculation.³ 
The crusts eventually dry, separate and disappear, leaving 
an area of erythema that heals without scarring.
The most common area is the face, especially around the 
mouth and nose. Most children are nasal carriers of the 
causative organisms. The trunk and limbs can also be 
affected. Lesions are usually localised. In severe cases, 
there may be regional lymphadenitis with fever and other 
constitutional symptoms. Widespread impetigo contagiosa 
is most common in the setting of secondarily infected 
atopic eczema.
Bullous impetigo
Bullous impetigo is almost always caused by Staphylococcus 
aureus. The organisms can readily be cultured from blister 
fluid. Staphylococcally produced epidermolytic toxin has 
been recovered from the blister fluid in some cases, and it 
is accepted as the basis for the bullae formation. Bullous 
impetigo is usually sporadic but clusters of cases may 
occur in families, and larger outbreaks are occasionally 
seen in institutions.¹ 
In bullous impetigo, the bullae are less rapidly ruptured. 
They become much larger and may last for two to three 
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days. When bullae rupture, yellow crusts with oozing 
result. A pathognomonic finding is a “collarette” of scale 
surrounding the blister roof at the periphery of the ruptured 
lesions. Lesions may look circinate due to central healing 
and peripheral extension.¹ They may continue to enlarge, 
forming polycyclic patterns.³ Bullae may occur anywhere and 
may be widely and irregularly distributed. Although impetigo 
is mainly a clinical diagnosis, it is worthwhile to get a pus 
swab from the lesions or exudates to confirm the diagnosis. 
Microscopy, culture and sensitivity are also necessary to 
guide the choice of antibiotic agents for treatment.4 This 
will also help to identify cases of community-associated 
methicillin-resistant Staphylococcus aureus (MRSA).
Treatment
For mild, localised infections a topical antibiotic alone 
may be enough. In both staphylococcal and streptococcal 
impetigo, mupirocin ointment has shown good results.5 
Fucidic acid is also effective against both organisms.5 Other 
topical antibiotics such as bacitracin and neomycin are less 
effective.5
Disadvantages of topical therapy relate to compliance 
problems for extensive disease, and failure to eradicate 
organisms on uninvolved skin or in respiratory tract 
reservoirs, which is particularly important in clinical settings 
of epidemic impetigo.³
In widespread or severe cases where systemic therapy is 
required, cloxacillin, amoxycillin/clavulanate and cephalexin 
are drugs of choice, but patterns of resistance must be 
considered. Erythromycin is less effective as resistance 
against it is rising.5 Penicillin VK is not appropriate oral 
therapy for impetigo. 3,5 For community-associated MRSA, 
drugs like vancomycin, clindamycin or linezolid should be 
prescribed. However, resistance of community-associated 
MRSA to some of these agents does occur.6,7
Complications
In untreated cases, the disease may spread to other areas 
of the body.
• Staphylococcal impetigo with strains producing toxic 
shock syndrome toxin-1 (TSST-1) may lead to toxic 
shock syndrome in children.
• Staphylococcal osteomyelitis, septic arthritis and 
pneumonia can occur, but such a severe disease 
progression is usually limited to children with acquired or 
inherited immune deficiencies.
• Certain nephritogenic strains of group A β-haemolytic 
streptococci may cause poststreptococcal glomeru-
lonephritis, possibly by way of antigenic mimicry. 
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Figure 1. Impetigo contagiosa around the nose and mouth in a child. Note 
the crusting and honey-coloured exudates.
Figure 2. Impetigo contagiosa. Note the purulent exudation.
